Thames Capital Management LLC Makes New $6.47 Million Investment in Semler Scientific, Inc. (NASDAQ:SMLR)

Thames Capital Management LLC purchased a new position in shares of Semler Scientific, Inc. (NASDAQ:SMLR) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 119,722 shares of the company’s stock, valued at approximately $6,465,000. Semler Scientific comprises about 1.8% of Thames Capital Management LLC’s portfolio, making the stock its 25th largest position. Thames Capital Management LLC owned approximately 1.29% of Semler Scientific at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Shariaportfolio Inc. increased its stake in Semler Scientific by 4.5% during the 4th quarter. Shariaportfolio Inc. now owns 160,453 shares of the company’s stock valued at $8,664,000 after purchasing an additional 6,837 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Semler Scientific by 3.3% during the fourth quarter. Geode Capital Management LLC now owns 140,423 shares of the company’s stock valued at $7,584,000 after buying an additional 4,464 shares during the last quarter. State Street Corp increased its position in shares of Semler Scientific by 0.6% in the 3rd quarter. State Street Corp now owns 118,223 shares of the company’s stock valued at $2,784,000 after acquiring an additional 725 shares during the period. Principal Financial Group Inc. raised its stake in Semler Scientific by 633.1% in the 4th quarter. Principal Financial Group Inc. now owns 112,487 shares of the company’s stock worth $6,074,000 after acquiring an additional 97,144 shares during the last quarter. Finally, LPL Financial LLC lifted its position in Semler Scientific by 25.3% during the 4th quarter. LPL Financial LLC now owns 110,633 shares of the company’s stock worth $5,974,000 after acquiring an additional 22,305 shares during the period. Institutional investors and hedge funds own 49.37% of the company’s stock.

Analysts Set New Price Targets

Separately, Lake Street Capital raised their price objective on Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a research note on Friday, January 24th.

Semler Scientific Trading Down 0.6 %

Shares of NASDAQ SMLR opened at $33.85 on Friday. The company has a 50 day simple moving average of $42.85 and a two-hundred day simple moving average of $45.13. The stock has a market cap of $324.86 million, a price-to-earnings ratio of 6.89 and a beta of 1.29. Semler Scientific, Inc. has a 12 month low of $20.88 and a 12 month high of $81.56.

Semler Scientific (NASDAQ:SMLR) last posted its earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.20 by $3.21. The company had revenue of $12.41 million during the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.